Kevin Hampel

6PUBLICATIONS
37CO-AUTHORS
Epidemiological methodsCellular nervous systemRheumatology and arthritisCognitionDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 21, 2026
DECREASE study: A European pool-analysis of patients with significant reductions in concomitant antiseizure medications in cenobamate Early Access Programs.

|Jan 28, 2026
Freedon study: Real-life outcomes of cenobamate in different lines of treatment.

Vicente Villanueva, José María Serratosa, Alejandro Fernández-Cabrera

|Oct 29, 2024
BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice.

Vicente Villanueva, Esther González Villar, Alejandro Fernandez-Cabrera

|Nov 03, 2023
Prospective study of cenobamate on cognition, affectivity, and quality of life in focal epilepsy.

Judit Catalán-Aguilar, Kevin G Hampel, Irene Cano-López

|May 07, 2023
Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program.

Vicente Villanueva, Daniel Santos-Carrasco, Pablo Cabezudo-García

|Feb 11, 2022
Clinical utility of Epitrack for differentiating profiles and patterns of post-surgical change in memory and quality of life in patients with drug-resistant epilepsy.

Alejandro Lozano-García, Kevin G Hampel, Antonio Gutiérrez

Pageof 1

Frequent Collaborators

4 joint publications

Vicente Villanueva

3 joint publications

Juan Rodriguez-Uranga

2 joint publications

Irene Cano-López

2 joint publications

Esperanza González-Bono